Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults

Study EBSI-CV-317-007 is a field study to evaluate the efficacy, immunogenicity, and safety of CHIKV VLP vaccine. The study was designed using infectious disease models and advanced analytics to guide region and clinical site prioritization, define the timing of study activities, and optimize the study parameters to local epidemiological conditions for CHIKV disease to overcome the challenges of assessing efficacy for CHIKV VLP vaccine.

Participants needed: 6,144
Trial details
Phase: Phase 3Age: 12+Biological sex: AllType: InterventionalSponsor: Bavarian NordicUpdated: Jun 29, 2026Locations: 3
Eligibility criteria

Able and willing to provide informed consent (and assent, as applicable) volunta... [+6]

Currently pregnant or breastfeeding. [+13]

Status: Recruiting

A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

The goal of this multi-center, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity of CHIKV VLP Vaccine in children 1 to \<12 years of age.

Participants needed: 720
Trial details
Phase: Phase 3Age: 1-11Biological sex: AllType: InterventionalSponsor: Bavarian NordicUpdated: Mar 24, 2026Locations: 15
Eligibility criteria

Males or females between 1 and <12 years of age at Day 1 (day of vaccination). N... [+4]

Participation or planned participation in an investigational clinical study (eg,... [+16]